Bacchus-S to determine as a quasi-drug category next week.

Published: 2004-11-11 06:59:00

Updated: 2004-11-11 06:59:00

The KFDA mulls over as to whether Bacchus S, a symbolic brand of tonic drink in Korea, should be approved as a quasi-drug, taking quite a long time by deferring its final conclusion. However, it seems to be finalized some time during the next week. Dong-A earlier requested for the KFDA to permit ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK